Skip to content

Application of dexmedetomidine intranasal in pediatric ophthalmology clinic

Application of dexmedetomidine nasal anesthesia in children's corneal suture removal

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044566
Enrollment
Unknown
Registered
2021-03-24
Start date
2021-03-31
Completion date
Unknown
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ophthalmology outpatient examination Sedation of children

Interventions

Group 1:dexmedetomidine nasal anesthesia 2µg/kg
Group 2:dexmedetomidine nasal anesthesia 3µg/kg

Sponsors

Affiliated Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 6 Years

Inclusion criteria

Inclusion criteria: 1. Anesthesiologists (ASA) physical status 1–2; 2. Children who do not cooperate with ophthalmic clinic examination or treatment; 3. Aged from 3 months to 6 years; 4. Informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1. Children with gastro-esophageal reflux, nausea and vomiting, apnea in the past 3 months, recent pneumonia, exacerbation of asthma, bronchitis and upper respiratory tract infection, bradycardia, and facial abnormalities, 2. Allergy to dexmedetomidine or chloral hydrate; 3. Weight 30 kg were excluded.

Design outcomes

Primary

MeasureTime frame
effectiveness;

Secondary

MeasureTime frame
Safety;

Countries

China

Contacts

Public ContactChen Chaoqiao

Affiliated Eye Hospital of Wenzhou Medical University

76352859@qq.com+86 15867101947

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026